Overall Status

Recruiting (3)

Enrolling by invitation (1)

Phase

n/a (2)

phase 1 (1)

Sponsor

CancerCare Manitoba (1)

Chang Gung Memorial Hospital (1)

Inspirna, Inc. (1)

Tufts University (1)

Collaborator

Fox Chase Cancer Center (1)

M.D. Anderson Cancer Center (1)

Ohio State University (1)

Tufts Medical Center (1)

Varian Medical Systems (1)

Study Documents

Intervention Type

behavioral (1)

device (1)

drug (1)

other (1)

Funder Type

Other (3)

Industry (1)

Study Type

Interventional (3)

Observational (1)

lung cancer recurrent

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Endometrial Cancer, Endometrial Cancer Recurrent, Lung Cancer Recurrent Trial in United States (RGX-104, Nivolumab, Ipilimumab)

Recruiting

Endometrial Cancer
+5 more

RGX-104
+6 more

Los Angeles, California
+13 more

Jul 21, 2022

Recurrent Predictive Power of Circulating Tumor Cells for Non

Enrolling by invitation

Lung Cancer Recurrent

Taoyuan, Taiwan

Chang Gung Memorial Hospital

Mar 14, 2022

Lung Cancer, Small Cell, Lung Cancer Metastatic, Lung Cancer Recurrent Trial in United States (Nutritional Counseling, Medically

Recruiting

Lung Cancer, Small Cell
+5 more

Nutritional Counseling
+5 more

Boston, Massachusetts
+3 more

Jul 30, 2021

Lung Cancer Stage I, Lung Cancer Stage II, Lung Cancer, Nonsmall Cell Trial in Winnipeg (Real-Time Position Transponder Beacons)

Recruiting

Lung Cancer Stage I
+4 more

Real-Time Position Transponder Beacons

Winnipeg, Manitoba, Canada
+1 more

Jan 26, 2021